4.5 Article

Effect of 2 years of calorie restriction on liver biomarkers: results from the CALERIE phase 2 randomized controlled trial

Journal

EUROPEAN JOURNAL OF NUTRITION
Volume 60, Issue 3, Pages 1633-1643

Publisher

SPRINGER HEIDELBERG
DOI: 10.1007/s00394-020-02361-7

Keywords

Energy restriction; Liver enzymes; Bilirubin; Cardiometabolic health; Aging

Funding

  1. National Institute on Aging, National Institutes of Health [U01AG022132, U01AG020478, U01AG020487, U01AG020480]
  2. National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health [U01AG022132, U01AG020478, U01AG020487, U01AG020480]
  3. National Obesity Research Center - National Institute of Diabetes and Digestive and Kidney Diseases [P30 DK072476]
  4. National Institute of General Medical Sciences of the National Institutes of Health - Louisiana Clinical and Translational Science Center [1 U54 GM104940]
  5. American Heart Association [20POST35210907]
  6. National Institutes of Health National Research Service Award [T32 DK064584]

Ask authors/readers for more resources

The study shows that a 2-year calorie restriction in metabolically healthy individuals without obesity can improve several liver biomarkers, with potentially greater improvements in men. These findings suggest that sustained calorie restriction may reduce long-term liver and metabolic disease risk in healthy adults.
Purpose Calorie restriction (CR) is an effective treatment for obesity-related liver and metabolic disease. However, CR studies in individuals without obesity are needed to see if CR could delay disease onset. Liver biomarkers indicate hepatic health and are linked to cardiometabolic disease. Our aim was to examine the effects of a 2-year CR intervention on liver biomarkers in healthy individuals without obesity. Methods The Comprehensive Assessment of Long-term Effects of Reducing Intake of Energy (CALERIE) study was a 2-year randomized controlled trial. Overall, 218 participants (body mass index: 25.1 +/- 1.7 kg/m(2)) were enrolled into a control group (n = 75) that ate ad libitum (AL), or a CR group (n = 143) that aimed to decrease energy intake by 25%. Alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), gamma-glutamyl transferase (GGT), and bilirubin were measured during the trial. Results At month 24, relative to the AL group, ALP (- 7 +/- 1 IU/L;P < 0.01) and GGT (- 0.11 +/- 0.04 log IU/L;P = 0.02) decreased and bilirubin increased (0.21 +/- 0.06 log mg/dL;P < 0.01) in the CR group; no between-group differences in ALT (- 1 +/- 1 IU/L;P > 0.99) or AST (2 +/- 2 IU/L;P = 0.68) were revealed. However, sex-by-treatment-by-time interactions (P < 0.01) were observed, with CR (vs. control) inducing reduced ALT and GGT and increased AST in men only (P <= 0.02). Conclusions In metabolically healthy individuals without obesity, 2 years of CR improves several liver biomarkers, with potentially greater improvements in men. These data suggest that sustained CR may improve long-term liver and metabolic disease risk in healthy adults.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available